McMillan Shakespeare Limited may be a bargain opportunity for investors

First-half 2014 profits were way down, but the business is intact.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The half-year report of vehicle fleet leasing management company McMillan Shakespeare Limited (ASX: MMS) showed how it was materially affected by the proposed Fringe Benefit Tax changes put forward by the previous Federal government. The steep drop in net profit confirmed how severe the cut in business would have been had those legislative changes been made.

Between 2007 and 2012, the corresponding half-year revenues have been rising at a compound annual growth rate of 38.4%, then suddenly with half-year results released this month it is only up about 1% to $162 million. On top of that, even though the revenue was just a smidgen higher, the rise in expenses relating to employees and their retention during the troubled time up to and past the Federal election brought the half-year net profit down by 35% to $19.2 million, compared to the previous corresponding period’s $29.7 million.

Looking to grow the business, its acquisition of vehicle fleet management CLM in the UK was completed in October, and it will be working with the joint venture that the company and another UK vehicle fleet leasing management company called Maxxia already has in place. The expansion into the UK is relatively recent, so that will be a positive in upcoming reporting seasons.

After the proposed legislation was scrapped, the company began to ramp up business to return to the level it was at before the shock announcement. This has been ongoing, but this half year could not avoid being affected by it.

The company’s share price has still not made its way back to the $18 range it was at in July last year before plummeting to $6.75. It has recovered back to the $11-$12 a share range now. Even though those FBT changes are dead and buried, investors are waiting for the previous earnings levels and growth rates to return.

Foolish takeaway

I have written this before, but the company still has all its structure intact and the business model or its industry conditions haven’t changed really. This may be an opportunity for investors to take a position in a good company that had a terrible year by no fault of its own.

If the original earning power is still there, then it is possibly selling at a discount. That is maybe when we can get great companies at good prices.

Motley Fool contributor Darryl Daté-Shappard does not own shares in any company mentioned. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

asx share price competitions represented by businessmen arm wrestling
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

person reading news on mobile phone
⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »